Juhani Kahri
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 28, 2020
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Journal: Journal of internal medicine
Published: December 18, 2019
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects.
Journal: Journal of clinical lipidology
Published: August 22, 2019
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics.
Journal: Journal of internal medicine
Published: February 20, 2019
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia.
Journal: Diabetes, obesity & metabolism
Published: February 05, 2019
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 03, 2016
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 14, 2015
Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026